• New Alzheimer's Trial Data; Microbiome and MS; Monkeypox's Neuro Complications

    6 days ago - By MedPageToday

    The oral beta-amyloid blocker ALZ-801 reduced plasma phosphorylated tau by 41% and preserved hippocampal volume in a phase II study of Alzheimer's patients with an APOE4 allele, Alzheon announced...
    Read more ...